Last update 08 May 2025

Bone resorption factor x RANKL

Basic Info

Related Targets
Bone resorption factorRANKL

Related

1
Drugs associated with Bone resorption factor x RANKL
AP-002
Target
Bone resorption factor x RANKL
Mechanism
Bone resorption factor inhibitors [+2]
Active Org.-
Originator Org.
MedMelior, Inc.MedMelior, Inc.
Active Indication-
Inactive Indication
Relapsed Solid Neoplasm [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Bone resorption factor x RANKL
NCT04143789
/ Unknown statusPhase 1/2
A Phase 1/2 Dose Escalation Study of AP-002 In Patients With Advanced or Recurrent Solid Tumors
100 Clinical Results associated with Bone resorption factor x RANKL
Login to view more data
100 Translational Medicine associated with Bone resorption factor x RANKL
Login to view more data
0 Patents (Medical) associated with Bone resorption factor x RANKL
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free